Innovative YSGG Laser Protocol Unveiled at AAP 2025
BIOLASE, the leader in dental laser technology, is set to unveil a pioneering development in periodontal treatment. During the American Academy of Periodontology (AAP) 2025 Corporate Forum, scheduled for October, the company will showcase a breakthrough YSGG laser protocol aimed at enhancing treatment predictability and efficacy in managing periodontitis.
Exciting Session by Dr. Philip Kang
Leading the charge for this innovative session will be Dr. Philip Kang, DDS. He is scheduled to present "Redefining Periodontitis Treatment: A Novel YSGG Laser-Resective Protocol for Predictable Pocket Elimination". This session promises to provide valuable insights into a technique poised to change the landscape of periodontal care.
Transforming Periodontitis Treatment
The presentation will offer a deep dive into a revolutionary Er,Cr:YSGG laser-assisted surgical protocol. This new approach is designed to standardize the treatment of periodontitis, aiming for increased predictability, greater efficiency, and improved comfort for patients. Attendees can look forward to learning how this protocol enables significant advancements such as:
- Predictable pocket elimination
- Enhanced bacterial decontamination
- Precise osseous contouring with minimal invasiveness
Advancements in Periodontal Health
This innovative protocol effectively leverages YSGG laser technology to foster consistent, long-term periodontal health. It positions the laser as an indispensable tool in contemporary periodontics, addressing the increasing demand for minimally invasive treatments.
Live Demonstrations and Exclusive Giveaways
BIOLASE invites attendees at AAP 2025 to explore Booth #1004. Here, they will witness live demonstrations of the Waterlase iPlus Premier Edition—the company's state-of-the-art all-tissue laser. Participants who engage with the Waterlase iPlus will be rewarded with a complimentary BIOLASE travel mug, adding an exciting incentive to visit the booth.
Proven Efficacy of Waterlase iPlus
The Waterlase iPlus is supported by an influential blind study conducted by The McGuire Institute, published in a reputable journal, confirming its effectiveness. The findings highlight significant benefits including:
- Reduction in bleeding, swelling, and postoperative discomfort
- Faster procedural times with outcomes equivalent to traditional open flap techniques
- Enhanced patient-reported outcomes consistent with AAP's Best Evidence Consensus recommendations
Commitment to Laser Dentistry
Dr. Kwang Bum Park, CEO of BIOLASE, remarked, "Our commitment to advancing the science and precision of laser dentistry enables us to provide superior patient care. Our participation in AAP 2025 highlights our dedication to continuous innovation that empowers clinicians and improves treatment outcomes for patients globally."
About BIOLASE
BIOLASE stands as the world’s foremost innovator in dental laser technology, manufacturing high-performance laser systems that not only advance dental practices but also elevate patient experiences. With more than thirty years of legacy, BIOLASE continues to shape the future of minimally invasive dentistry.
Contact Information
For further inquiries, please reach out to Denise Arterberry, Marketing Manager at BIOLASE, via email at darterberry@biolase.com or call 949.226.8190.
Frequently Asked Questions
What is the YSGG laser protocol introduced by BIOLASE?
The YSGG laser protocol is a new technique aiming to improve treatment predictability and comfort for periodontitis.
When and where will the presentation occur?
The presentation will take place during the AAP 2025 Corporate Forum, focusing on innovative dental techniques.
What are the benefits of the Waterlase iPlus?
The Waterlase iPlus minimizes pain, reduces recovery time, and provides effective treatment outcomes.
Who is Dr. Philip Kang?
Dr. Philip Kang is a noted dental professional leading the featured session on the new laser protocol.
How can I learn more about BIOLASE?
For more information, you can visit the official BIOLASE website or contact their media relations directly.
